BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech

AstraZeneca’s AIRSUPRA Cuts Severe Asthma Exacerbations by 47%, Redefines Mild Asthma Treatment Standard

AIRSUPRA demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone Full results published in th...

May 20, 2025 | News

Lunit Expands U.S. Footprint with AI-Powered Breast Cancer Screening at Over 200 Sites

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imagi...

May 20, 2025 | News

Docquity’s Christophe Meugnier on Powering Patient Support with Digital Precision Across Southeast Asia

In this interview with BioPharma APAC, Christophe Meugnier, Chief Commercial Officer and General Manager of Vietnam & Thailand at Do...

May 19, 2025 | Interview

iotaMotion Marks International Milestone with First Use of iotaSOFT® System in Zurich Cochlear Implant Study

iotaMotion, Inc., a leader in robotic-assisted systems for cochlear implant surgery, announced the first use of the iotaSOFT® Insertion Syst...

May 14, 2025 | News

BD Launches FACSDiscover™ A8 Cell Analyzer to Expand Access to Advanced Spectral and Real-Time Imaging Technologies

New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma BD (Becton...

May 14, 2025 | News

Nordic Bioscience and Roche Launch Elecsys PRO-C3 Test to Advance Liver Fibrosis Assessment on cobas Analyzers

Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used w...

May 09, 2025 | News

Connext Completes Phase 1 for CNT201, Eyes Phase 2 Launch and Expansion into Peyronie’s Disease

Conducted under U.S. FDA-cleared IND– Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie's disease Connext, a clinical s...

May 09, 2025 | News

Aroa Biosurgery Surpasses 100 Peer-Reviewed Studies Validating AROA ECM Technology in Wound Care

Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed stud...

May 05, 2025 | Report

Siemens Healthineers Launches MAMMOMAT B.brilliant to Advance Early Breast Cancer Detection in Indonesia

Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to the...

May 02, 2025 | News

AstraZeneca and Qure.ai Hit 5 Million AI-Enabled Chest X-Rays Milestone Across LMICs

AstraZeneca, in partnership with health-tech company Qure.ai, announced the successful completion of 5 million artificial intelligence (AI) enabled chest X...

May 01, 2025 | News

SimonMed Partners with Lunit to Advance AI-Powered Breast Cancer Detection Across the U.S.

SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce thei...

April 24, 2025 | News

Transverse Medical Completes First Patient Series in Feasibility Study of POINT-GUARD™ CEP Device in Australia

Transverse Medical Inc. is excited to announce the completion of the first series of patients under its Feasibility Clinical Study at the prestigious Victo...

April 22, 2025 | News

Eisai and Biogen’s Leqembi® Secures First-of-Its-Kind EU Authorization for Early Alzheimer’s

Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi® (...

April 21, 2025 | News

Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics

Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...

April 18, 2025 | News

Stay Connected